Top Markets
Coin of the day
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
Clasificación en acciones #13229
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
Precio por acción
$4.99
Capitalización bursátil
$508.03M
Cambio (1 día)
-2.48%
Cambio (1 año)
2.10%
País
TW
Comercio Ever Supreme Bio Technology Co., Ltd (6712)

Categoría

Historial del precio de la acción de Ever Supreme Bio Technology Co., Ltd (6712)
Precio más alto de cierre: $4.88 el 2026-08-01

Precio más bajo de cierre: $1.98 el 2018-10-01
Historial del precio de la acción de Ever Supreme Bio Technology Co., Ltd desde 2018 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -4.84%
2025 8.48%
2024 -5.27%
2023 0.33%
2022 -5.52%
2021 21.39%
2020 20.06%
2019 82.02%
2018 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$541.44 38.47%
US
$1.03K 43.99%
NL
$121.01 -13.08%
AU
$142.74 492.53%
US
$749.90 5.87%
CH